Beyondspring Inc BYSI:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
0.9601quote price arrow down-0.0153 (-1.5686%)
Volume
78,179
52 week range
0.92 - 17.98
Loading...
  • Open0.9754
  • Day High0.9837
  • Day Low0.95
  • Prev Close0.9754
  • 52 Week High17.98
  • 52 Week High Date10/20/21
  • 52 Week Low0.92
  • 52 Week Low Date10/03/22

Key Stats

  • Market Cap37.38M
  • Shares Out38.93M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.09
  • YTD % Change-78.81

KEY STATS

  • Open0.9754
  • Day High0.9837
  • Day Low0.95
  • Prev Close0.9754
  • 52 Week High17.98
  • 52 Week High Date10/20/21
  • 52 Week Low0.92
  • 52 Week Low Date10/03/22
  • Market Cap37.38M
  • Shares Out38.93M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.09
  • YTD % Change-78.81

RATIOS/PROFITABILITY

  • EPS (TTM)-1.64
  • P/E (TTM)-0.58
  • Fwd P/E (NTM)-0.98
  • EBITDA (TTM)-66.179M
  • ROE (TTM)-111.59%
  • Revenue (TTM)1.35M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-5,048.70%
  • Debt To Equity (MRQ)5.88%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Beyondspring Inc

 

Profile

MORE
BeyondSpring Inc. is a clinical-stage global biopharmaceutical company. The Company is focused on developing cancer therapies to improve clinical outcomes for patients who have high unmet medical needs. The Company’s lead product Plinabulin, which is being studied as an anti-cancer agent in combination with docetaxel in advanced non-small cell lung cancer (NSCLC). The Plinabulin is a small molecule derived from a natural compound found in marine microorganisms. Its Plinabulin...
Lan Huang Ph.D.
Chairperson of the Board, Chief Executive Officer, Co-Founder
Elizabeth Czerepak
Chief Financial Officer
Ramon Mohanlal M.D., Ph.D.
Chief Medical Officer, Executive Vice President of Research and Development and Director
Address
28 Liberty St Fl 39
New York, NY
10005-1451
United States

Top Peers

SYMBOLLASTCHG%CHG
CYCN
Cyclerion Therapeutics Inc
0.9402+0.0072+0.77%
GANX
Gain Therapeutics Inc
3.12+0.01+0.32%
SLS
Sellas Life Sciences Group Inc
2.19+0.11+5.29%
HEPA
Hepion Pharmaceuticals Inc
0.51+0.0114+2.29%
OCUP
Ocuphire Pharma Inc
2.28-0.04-1.72%